Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT06464159
Recruiting
New Therapeutic Strategy Against Preeclampsia
Not applicable · France · 1 site
Registry update: 6 May 2026
NCT07285057
Recruiting
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Phase 2 · United States · 1 site
Registry update: 23 Feb 2026
NCT07369011
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Australia, Brazil, Canada, China, Germany, Spain, India, Japan, South Korea, Taiwan, United States · 115 sites
Registry update: 4 Nov 2026
NCT07421713
Recruiting
A Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older
Not applicable · United Kingdom, Netherlands · 3 sites
Registry update: 23 Oct 2026
NCT07227415
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Phase 1/2 · Australia, China, Germany, Spain, Japan, United States · 180 sites
Registry update: 8 Oct 2026
NCT07685457
Recruiting
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.
Not applicable · South Korea · 1 site
Registry update: 6 Jul 2026
2025-521919-39-00
Recruiting
A PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III melanoma in the adjuvant setting
Phase 1 · Spain, Greece, Italy, Romania · 34 sites
Registry update: 19 Oct 2026
NCT07427511
Recruiting
SwissNeuroRehab - HDHI
Not applicable · Switzerland · 5 sites
Registry update: 10 Mar 2026
NCT07573956
Recruiting
Trial Evaluating Hypo-fractionated Accelerated Versus Conventional Fractionated Adjuvant RT in Head & Neck Malignancies
Phase 2/3 · India · 1 site
Registry update: 7 May 2026
NCT06854198
Recruiting
Glaucoma Screening to Enhance At-Risk Californians' Health
Not applicable · United States · 3 sites
Registry update: 14 Oct 2026
NCT07392190
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Australia, Belgium, Brazil, China, Czechia, Spain, Israel, India, Japan, Mexico, Puerto Rico, Romania, Taiwan, United States · 186 sites
Registry update: 4 Nov 2026
NCT07867522
Recruiting
Prevention of Bile Leakage After Liver Resection in Children
Not applicable · Russia · 1 site
Registry update: 9 Oct 2026
NCT07409077
Recruiting
Efficacy of Biofeedback Training for Glaucoma
Not applicable · Canada · 1 site
Registry update: 13 Feb 2026
NCT07305454
Recruiting
Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases
Not applicable · France · 1 site
Registry update: 13 Feb 2026
NCT07335887
Recruiting
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis
Phase 2 · China · 3 sites
Registry update: 28 Jul 2026
NCT07206121
Recruiting
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Not applicable · United States · 1 site
Registry update: 11 Feb 2026
NCT07390890
Recruiting
DSLT for Reducing Medication in Glaucoma
Not applicable · United States · 1 site
Registry update: 20 Apr 2026
NCT07389590
Recruiting
Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
Phase 4 · United States · 1 site
Registry update: 6 May 2026
NCT07377643
Recruiting
IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
Phase 3 · China · 1 site
Registry update: 25 Feb 2026
NCT07332455
Recruiting
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Phase 1/2 · Australia, Canada, Spain, France, Japan, South Korea, Netherlands, United States · 17 sites
Registry update: 9 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.